Assessing excellence in translational cancer research: a consensus based framework
Open Access
- 29 October 2013
- journal article
- review article
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 11 (1) , 274
Abstract
It takes several years on average to translate basic research findings into clinical research and eventually deliver patient benefits. An expert-based excellence assessment can help improve this process by: identifying high performing Comprehensive Cancer Centres; best practices in translational cancer research; improving the quality and efficiency of the translational cancer research process. This can help build networks of excellent Centres by aiding focused partnerships. In this paper we report on a consensus building exercise that was undertaken to construct an excellence assessment framework for translational cancer research in Europe.Keywords
This publication has 6 references indexed in Scilit:
- Critical Appraisal of Translational Research Models for Suitability in Performance Assessment of Cancer CentersThe Oncologist, 2012
- Defining Success for Translational Research OrganizationsScience Translational Medicine, 2011
- Traversing the Valley of Death: A Guide to Assessing Prospects for Translational SuccessScience Translational Medicine, 2009
- Constructive Technology Assessment (CTA) as a tool in Coverage with Evidence Development: The case of the 70-gene prognosis signature for breast cancer diagnosticsInternational Journal of Technology Assessment in Health Care, 2009
- The Stockholm DeclarationMolecular Oncology, 2008
- Practice-Based Research—“Blue Highways” on the NIH RoadmapJAMA, 2007